 Connection
Dianna Quan to Amyloid Neuropathies, Familial
This is a "connection" page, showing publications Dianna Quan has written about Amyloid Neuropathies, Familial.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.226 |
|
|
|
-
Quan D, Obici L, Berk JL, Ando Y, Aldinc E, White MT, Adams D. Impact of baseline polyneuropathy severity on patisiran treatment outcomes in the APOLLO trial. Amyloid. 2023 Mar; 30(1):49-58.
Score: 0.835
-
Quan D, Cohen JA. Clinical variant of familial amyloid polyneuropathy. Muscle Nerve. 2002 Sep; 26(3):417-20.
Score: 0.208
-
Adams D, Polydefkis M, Gonz?lez-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada L?pez IA, Dispenzieri A, Quan D, Concei??o IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Plant?-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Lancet Neurol. 2021 01; 20(1):49-59.
Score: 0.184
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|